A class action lawsuit was filed in New York federal court on Friday accusing Novo Nordisk (NVO) of running a "pay-for-delay" ...

Smith ⁠Drug asked the court for an unspecified amount of monetary damages on behalf of a proposed class of Victoza purchasers ...

Danish drugmaker Novo Nordisk faces a class action lawsuit in New York. The company is accused of using its patents to keep a ...

Novo Nordisk AS was sued in federal court Friday with allegations that it monopolized the blockbuster weight loss medication Victoza through an illegal deal with a competitor to delay the generic, ...

Generic Victoza is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older, with Type 2 diabetes mellitus. Lupin is releasing ...

Novo Nordisk faces a class action lawsuit for allegedly monopolizing its diabetes drug Victoza through patent misuse and ...